Uses of diterpenoid triepoxides as an anti-proliferative agent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S291000, C514S468000

Reexamination Certificate

active

06949510

ABSTRACT:
Combinations of diterpenoid triepoxides and anti-proliferative agents are used in a combination therapy to treat hyperproliferative disorders. Anti-proliferative agents of interest include agents active in killing tumor cells, as well as immunosuppressants, and a variety of other agents that reduce cellular proliferation in targeted tissues. Synergistic combinations provide for comparable or improved therapeutic effects, while lowering adverse side effects.

REFERENCES:
patent: 5294443 (1994-03-01), Lipsky et al.
patent: 5496846 (1996-03-01), Wilson et al.
patent: 5759550 (1998-06-01), Wiedmann et al.
patent: 5843452 (1998-12-01), Wiedmann et al.
patent: 5919816 (1999-07-01), Hausheer et al.
patent: WO 95/15174 (1995-06-01), None
patent: WO 97/31921 (1997-09-01), None
patent: WO 00/48619 (2000-08-01), None
Lee et al., PG490 (Triptolide) Cooperates With Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells, The Journal of Biol. Chem., 1999, 274(19): 13451-13455.
Gu et al. (1995), “Isolation, Purification, and Characterization of Immunosuppressive Compounds from Tripterygium: Triptolide and Tripdiolide,”Int. J. Immunopharmac., vol. 17(5):351-356.
Lee et al. (1999), “PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells,”Journal of Biochemistry, vol. 274(19):18451-18455.
Qiu et al. (1999), “Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box/Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation,”Journal of Biological Chemistry, vol. 274(19):13443-13450.
Shamon et al. (1997), “Evaluation of the Mutagenic, Cytotoxic, and Antitumor Potential of Triptolide, a Highly Oxygenated Diterpene Isolated fromTripterygium Wilfordii,” Cancer Letters, vol. 112:113-117.
Tengchaisri et al. (1998), “Antitumor Activity of Triptolide Against Cholangiocarcinoma Growth in Vitro and in Hamsters,”Cancer Letters, vol. 133:169-175.
Yang et al. (1998), “Triptolide Induces Apoptotic Death of T lymphocyte,”Immunopharmacology, vol. 40:139-149.
Lievano et al., Antitumor Effect of CPT-11, a New Derivative of Camptothecin, Against Human Prostate Cancer (PC-3) in Vitro and Prostate Rat Tumor (AT-3) in Vivo, Methods Find Exp Clin Pharmacol., 1996, 18(10): 659-62.
Wei et al., Inhibitory Effect of Triptolide on Colony Formation of Breast and Stomach Cancer Cell Lines, Cell Growth Factor Division, 1991, 12(5): 406-10.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Uses of diterpenoid triepoxides as an anti-proliferative agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of diterpenoid triepoxides as an anti-proliferative agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of diterpenoid triepoxides as an anti-proliferative agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3401561

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.